ARCHIVES

Pazdur: Registration Trials Run By Groups Need Same Rigor As Industry Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Breast Density Does Not Raise Breast Cancer Death Rates

August 31, 2012

Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation

August 29, 2014

Columnist, Kushner, Four Others Names To NCAB

May 9, 1980

NCI Advisors Approve New Grant Programs In Systems Genetics, Tumor Stem Cells.

November 23, 2007

Duke Picks Lyerly To Direct Cancer Center

May 2, 2003

ASCO President Swain: “Shattering Impact on Cancer Enterprise”

February 15, 2013